CClinicalTrials.gg
CompletedNCT05373602Updated May 13, 2022

LARS for Chinese Patients

An observational study in Incidence and Risk Factors of Low Anterior Resection Syndrome, sponsored by Third Affiliated Hospital, Sun Yat-Sen University. Completed at 1 site in China. Per ClinicalTrials.gov, last updated 2022-05-13.

Sponsored by Third Affiliated Hospital, Sun Yat-Sen University · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
261
Sex
All
01

Study summary

Low anterior resection syndrome (LARS) frequently occurs in patients undergoing low anterior resection (LAR). However, the incidence, exact mechanism and risk factors of major LARS largely variate in different studies. Considering varieties and differences of patient characteristics between Chinese patients and the western ones, this retrospective study aims to investigate the incidence of LARS in Chinese patients undergoing laparoscopic LAR, and to explore perioperative risk factors that might be associated with major LARS. Consequent patients undergoing laparoscopic LAR and free from disease recurrence from January 2015 to May 2021 were issued with LARS questionnaire. Incidence of LARS and patient data were collected and analyzed.

02

Conditions studied

  • Incidence and Risk Factors of Low Anterior Resection Syndrome
03

In context

Low Anterior Resection Syndrome

85 studies on the registry are indexed under Low Anterior Resection Syndrome; 36 are open to participants now.

This study's enrollment of 261 is above the median of 125 across 27 observational studies indexed under Low Anterior Resection Syndrome.

Browse Low Anterior Resection Syndrome studies →

Lead sponsor

Third Affiliated Hospital, Sun Yat-Sen University is the lead sponsor of 130 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

rectal cancer patients

Inclusion criteria

Patients diagnosed as rectal cancer and underwent radical laparoscopic LAR and straight colorectal/coloanal anastomosis (with or without a protective stoma) by a same surgical team

Exclusion criteria

Exclusion Criteria:

either local or distal recurrence, severe complications such as postoperative anastomotic leakage, failure of protective stoma closure, data missed and no responding to LARS questionnaire

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
261 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testLARS questionnaire

    Eligible participants were issued with LARS questionnaire (Chinese version) by E-mail, message, phone or face to face interview.

06

What researchers measure

Primary outcomes

  1. incidence of LARS

    incidence of Low Anterior Resection Syndrome

    Time frame: at least 1 months postoperatively

  2. incidence of major LARS

    incidence of major Low Anterior Resection Syndrome

    Time frame: at least 1 months postoperatively

07

Study locations

1 site
  • the Third Affiliated Hospital of Sun Yat-Sen University
    Guangzhou, Guangdong 510630, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05373602
Lead sponsor
Third Affiliated Hospital, Sun Yat-Sen University
Responsible party
Hongbo Wei (Vice-president of Third Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University) — Principal investigator
First posted
May 13, 2022
Start date
Jan 2015
Primary completion
May 2021
Completion
May 2021
Last update
May 13, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion